← Back
$MAZE All transactions

Maze Therapeutics, Inc.

A

$ Value

$0

Shares

16,000

Price

$0

Filed

Mar 3

Insider

Name

Courtney Phillips

Title

GC and Corp. Secretary

CIK

0001782758

Roles

Officer

Transaction Details

Transaction Date

2026-03-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

16,000

Footnotes

The option award shall vest as to 1/48 of the total award monthly, with the first tranche vesting on April 1, 2026, subject to the reporting person's continued service to the Issuer on each vesting date. | Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. | The restricted stock unit award shall vest in ratable increments of 1/4 of the total award, with the first tranche vesting on March 1, 2027, and vesting thereafter on the one year anniversary of such date, subject to the reporting person's continued service to the Issuer on each vesting date. | These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

Filing Info

Accession No.

0001782758-26-000002

Form Type

4

Issuer CIK

0001842295

Courtney Phillips's History

Date Ticker Type Value
2026-03-02 MAZE A $0
2026-03-02 MAZE A $0
2025-09-22 MAZE A $0

Other Insiders at MAZE (90d)

Insider Bought Sold Last
Coloma Jason V
Chief Executive Officer
2026-03-02
Kumar Neil 2026-03-27
Courtney Phillips
GC and Corp. Secretary
2026-03-02
Tahir Misbah
Chief Financial Officer
2026-03-02
Dandekar Atul
CSBO
$893K 2026-03-30
Bernstein Harold
President, R&D & CMO
$3.4M 2026-04-01
Bachrodt Amy
SVP, Finance
$530K 2026-04-01